Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Childhood multiple sclerosis treated with plasmapheresis

I Takahashi1, Y Sawaishi, O Takeda

  • 1Department of Pediatrics, Akita University School of Medicine, Japan.

Pediatric Neurology
|July 1, 1997
PubMed
Summary

Plasmapheresis offers a promising alternative treatment for pediatric multiple sclerosis, particularly in severe or steroid-dependent cases. This therapy led to sustained remission in a young patient, suggesting its potential for long-term management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of an efficient production method for beta-mannosidase by the creation of an overexpression system in Aspergillus aculeatus.

Letters in applied microbiology·2007
Same author

Acid sphingomyelinase deficiency: cardiac dysfunction and characteristic findings of the coronary arteries.

Journal of inherited metabolic disease·2006
Same author

Effects of acute preload reduction on myocardial velocity during isovolumic contraction and myocardial acceleration in pediatric patients.

Pediatric cardiology·2006
Same author

Biochemical preparation of L-ribose and L-arabinose from ribitol: a new approach.

Journal of bioscience and bioengineering·2005
Same author

Preparation of L-talose and D-gulose from L-tagatose and D-sorbose, respectively, using immobilized L-rhamnose isomerase.

Journal of bioscience and bioengineering·2005
Same author

Production of D-lyxose from D-glucose by microbial and enzymatic reactions.

Journal of bioscience and bioengineering·2005

Area of Science:

  • Neurology
  • Immunology
  • Pediatrics

Background:

  • Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
  • Pediatric MS is rare, and treatment options, especially for severe or steroid-dependent cases, require further investigation.
  • High-dose corticosteroid therapy, while effective, carries significant side effects with frequent administration.

Observation:

  • A 7-year-old boy experienced three relapses of MS within 8 months, requiring repeated high-dose methylprednisolone treatment.
  • To mitigate steroid-related side effects, plasmapheresis was initiated during the third relapse.
  • Treatment involved initial plasmapheresis for 3 days, followed by intermittent sessions guided by antinuclear antibody (ANA) titers.

Findings:

  • The patient demonstrated marked clinical improvement following the introduction of plasmapheresis.

Related Experiment Videos

  • The boy remained relapse-free for over 18 months after commencing plasmapheresis.
  • This case highlights the potential efficacy of plasmapheresis in managing pediatric MS, particularly when linked to fluctuating ANA levels.

    • Implications:

    • Plasmapheresis may serve as a valuable alternative or adjunctive therapy for steroid-dependent or severe pediatric multiple sclerosis.
    • Monitoring antinuclear antibody titers could be a useful strategy in assessing disease activity and guiding plasmapheresis treatment in children.
    • Further research is warranted to establish the long-term safety and efficacy of plasmapheresis in the pediatric MS population.